[go: up one dir, main page]

CN110615764A - N- (2-benzamide) -1H-pyrazole-4-formamide compound and preparation method and application thereof - Google Patents

N- (2-benzamide) -1H-pyrazole-4-formamide compound and preparation method and application thereof Download PDF

Info

Publication number
CN110615764A
CN110615764A CN201911025678.4A CN201911025678A CN110615764A CN 110615764 A CN110615764 A CN 110615764A CN 201911025678 A CN201911025678 A CN 201911025678A CN 110615764 A CN110615764 A CN 110615764A
Authority
CN
China
Prior art keywords
pyrazole
methyl
difluoromethyl
formula
benzamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201911025678.4A
Other languages
Chinese (zh)
Inventor
刘幸海
余玮
金涛
谭成侠
翁建全
武宏科
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University of Technology ZJUT
Original Assignee
Zhejiang University of Technology ZJUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University of Technology ZJUT filed Critical Zhejiang University of Technology ZJUT
Priority to CN201911025678.4A priority Critical patent/CN110615764A/en
Publication of CN110615764A publication Critical patent/CN110615764A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/561,2-Diazoles; Hydrogenated 1,2-diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

本发明公开了一种N‑(2‑苯甲酰胺)‑1H‑吡唑‑4‑甲酰胺类化合物及其制备方法和应用。N‑(2‑苯甲酰胺)‑1H‑吡唑‑4‑甲酰胺类化合物,即N‑(2‑苯甲酰胺)‑3‑(二氟甲基)‑1‑甲基‑1H‑吡唑‑4‑甲酰胺类化合物,其结构式如式(Ⅰ)所示:式(Ⅰ)中:R为苯基或取代苯基,所述取代苯基的苯环上的取代基数量为一个或多个,各个取代基各自独立地选自卤素、C1‑C3烷基或C1‑C3烷氧基。本发明公开的N‑(2‑苯甲酰胺)‑3‑(二氟甲基)‑1‑甲基‑1H‑吡唑‑4‑甲酰胺类化合物为具有杀菌活性的新化合物,其在50ppm浓度下对水稻纹枯病菌有较好的抑制率,为新农药的研发提供了基础。The invention discloses an N-(2-benzamide) -1H -pyrazole-4-carboxamide compound, a preparation method and application thereof. N-(2-benzamide)-1 H -pyrazole-4-carboxamide compounds, namely N-(2-benzamide)-3-(difluoromethyl)-1-methyl-1 H Pyrazole-4-carboxamide compounds, its structural formula is shown in formula (I): In formula (I): R is phenyl or substituted phenyl, the number of substituents on the benzene ring of the substituted phenyl is one or more, and each substituent is independently selected from halogen, C1-C3 alkyl or C1-C3alkoxy. The N-(2-benzamide)-3-(difluoromethyl)-1-methyl-1 H -pyrazole-4-carboxamide compounds disclosed in the present invention are novel compounds with bactericidal activity, which are in 50ppm concentration of rice sheath blight has a good inhibition rate, which provides a basis for the research and development of new pesticides.

Description

一种N-(2-苯甲酰胺)-1H-吡唑-4-甲酰胺类化合物及其制备 方法和应用A kind of N-(2-benzamide)-1H-pyrazole-4-carboxamide compound and preparation thereof methods and applications

技术领域technical field

本发明涉及一种N-(2-苯甲酰胺)-1H-吡唑-4-甲酰胺类化合物及其制备方法和应用。The present invention relates to an N-(2-benzamide)-1H-pyrazole-4-carboxamide compound and a preparation method and application thereof.

背景技术Background technique

如今,吡唑酰胺类化合物由于含有吡唑、酰胺等高活性结构基团,通常具有低毒、高效等优良且广泛的生物活性,吡唑环作为含氮类杂环中的重要一员,它的结构形式非常独特,而且对多种微生物、致病因子和疾病都有很高的生物活性,所以不但被使用在杀菌、杀虫和杀螨领域,在除草领域也有广泛的应用,甚至在医药中的抗癌领域也有应用。近几年来国外一些跨国农药巨头对双酰胺类杀虫剂的开发也非常感兴趣,已经上市的有杜邦开发的氯虫苯甲酰胺、溴氰虫酰胺,拜耳和日本农药株式会社共同开发的氟苯虫酰胺。正在开发的有拜耳的Tetraniliprol,巴斯夫和三井化学开发的溴虫氟苯双酰胺等。该类化合物具有对植物的残留低、药害小、对哺乳动物的急性毒性低等优点。Nowadays, pyrazole amide compounds usually have excellent and extensive biological activities such as low toxicity and high efficiency due to their highly active structural groups such as pyrazole and amide. As an important member of nitrogen-containing heterocycles, pyrazole rings are Its structure is very unique, and it has high biological activity against a variety of microorganisms, pathogenic factors and diseases, so it is not only used in the field of sterilization, insecticidal and acaricidal, but also widely used in the field of weeding, and even in medicine It also has applications in the field of anticancer. In recent years, some foreign multinational pesticide giants are also very interested in the development of bisamide insecticides. The ones that have been listed include chlorantraniliprole and cyantraniliprole developed by DuPont, and fluorine fluoride jointly developed by Bayer and Japan Pesticide Co., Ltd. benzilamide. There are Tetraniliprol of Bayer, bromiliprole developed by BASF and Mitsui Chemicals, etc. under development. Such compounds have the advantages of low residues to plants, little phytotoxicity, and low acute toxicity to mammals.

设计合成新型的吡唑双酰类杀菌剂对我们开发高效、低毒、低残留的新型农药具有重要意义。The design and synthesis of new pyrazole bisacyl fungicides is of great significance for us to develop new pesticides with high efficiency, low toxicity and low residues.

发明内容SUMMARY OF THE INVENTION

针对现有技术存在的上述技术问题,本发明的目的在于提供一种N-(2-苯甲酰胺)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺类化合物及其制备方法和应用。本发明是基于氟唑菌酰胺等SDH抑制剂的结构,以吡唑酰胺结构为母体,引入延伸且引入取代苯甲酰胺等方式,并在吡唑环3位引入二氟甲基以考察对化合物生物活性的影响,设计合成了吡唑双酰类等系列化合物。In view of the above-mentioned technical problems existing in the prior art, the object of the present invention is to provide a kind of N-(2-benzamide)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-methyl Amide compound and its preparation method and application. The present invention is based on the structure of SDH inhibitors such as fluconazole, takes the pyrazole amide structure as the parent, introduces extension and substituted benzamide, etc., and introduces a difluoromethyl group at the 3-position of the pyrazole ring to investigate the compound The influence of biological activity, designed and synthesized a series of compounds such as pyrazole bisacyl.

所述的一种N-(2-苯甲酰胺)-1H-吡唑-4-甲酰胺类化合物,即N-(2-苯甲酰胺)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺类化合物,其特征在于其结构式如式(Ⅰ)所示:Described a kind of N-(2-benzamide)-1H-pyrazole-4-carboxamide compound, namely N-(2-benzamide)-3-(difluoromethyl)-1-formaldehyde Base-1H-pyrazole-4-carboxamide compound, characterized in that its structural formula is shown in formula (I):

式(Ⅰ)中:R为苯基或取代苯基,所述取代苯基的苯环上的取代基数量为一个或多个,各个取代基各自独立地选自卤素、C1-C3烷基或C1-C3烷氧基。In formula (I): R is phenyl or substituted phenyl, the number of substituents on the benzene ring of the substituted phenyl is one or more, and each substituent is independently selected from halogen, C1-C3 alkyl or C1-C3 alkoxy.

所述的一种N-(2-苯甲酰胺)-1H-吡唑-4-甲酰胺类化合物,其特征在于式(Ⅰ)中R为下列之一:2-甲基苯基、2,6-二氯苯基、2,3-二氯苯基、4-甲氧基苯基,2,4-二氯苯基、苯基。Described a kind of N-(2-benzamide)-1H-pyrazole-4-carboxamide compound, it is characterized in that in formula (I), R is one of the following: 2-methylphenyl, 2, 6-dichlorophenyl, 2,3-dichlorophenyl, 4-methoxyphenyl, 2,4-dichlorophenyl, phenyl.

所述的一种N-(2-苯甲酰胺)-1H-吡唑-4-甲酰胺类化合物的制备方法,其特征在于包括以下步骤:Described a kind of preparation method of N-(2-benzamide)-1H-pyrazole-4-carboxamide compound, it is characterized in that comprising the following steps:

1)二氟乙酰乙酸乙酯和原甲酸三乙酯在有机溶剂A中升温至回流反应,反应结束后浓缩除去溶剂,浓缩残留物加入到甲基肼水溶液与有机溶剂B的混合液中,于45-60℃温度下搅拌反应,TLC跟踪反应进程;反应结束后,反应液经后处理制得如式(Ⅱ)所示1-甲基-3-二氟甲基-1H-吡唑-4-甲酸乙酯;1) Ethyl difluoroacetoacetate and triethyl orthoformate are warmed to reflux reaction in organic solvent A, after the reaction is finished, the solvent is concentrated and removed, and the concentrated residue is added to the mixed solution of methyl hydrazine aqueous solution and organic solvent B, in The reaction was stirred at a temperature of 45-60 °C, and the reaction progress was tracked by TLC; after the reaction was completed, the reaction solution was post-treated to obtain 1-methyl-3-difluoromethyl-1H-pyrazole-4 shown in formula (II). - ethyl formate;

2)将步骤1)所得式(Ⅱ)所示1-甲基-3-二氟甲基-1H-吡唑-4-甲酸乙酯加入到质量浓度为8~12%的NaOH水溶液中,于55-70℃温度下搅拌反应至反应液体系呈透明状,自然冷却至室温后,加酸将反应液pH调至1.5-3.0,析出固体,抽滤,滤渣干燥得如式(Ⅲ)所示的1-甲基-3-二氟甲基-1H-吡唑-4-甲酸;2) 1-methyl-3-difluoromethyl-1H-pyrazole-4-carboxylic acid ethyl ester shown in the formula (II) obtained in step 1) was added to the NaOH aqueous solution with a mass concentration of 8 to 12%, and then Stir the reaction at a temperature of 55-70°C until the reaction liquid system is transparent, and after naturally cooling to room temperature, add acid to adjust the pH of the reaction liquid to 1.5-3.0, precipitate solids, filter with suction, and dry the filter residue to obtain the formula (III). 1-methyl-3-difluoromethyl-1H-pyrazole-4-carboxylic acid;

3)步骤2)所得式(Ⅲ)所示的1-甲基-3-二氟甲基-1H-吡唑-4-甲酸在二氯亚砜中升温至回流反应,反应结束后浓缩除去过量的二氯亚砜,浓缩残留物与N-Boc-乙二胺和三乙胺在有机溶剂C中于室温下搅拌反应,TLC跟踪反应进程,反应结束后蒸馏浓缩除去溶剂,蒸馏浓缩残余物经柱层析分离制得如式(Ⅳ)所示的(2-(3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺基)乙基)氨基甲酸叔丁酯;3) Step 2) The obtained 1-methyl-3-difluoromethyl-1H-pyrazole-4-carboxylic acid represented by the formula (III) is heated to reflux reaction in thionyl chloride, and after the reaction is finished, it is concentrated to remove excess thionyl chloride, the concentrated residue was reacted with N-Boc-ethylenediamine and triethylamine in organic solvent C at room temperature, and the reaction progress was followed by TLC. After the reaction was completed, the solvent was distilled and concentrated to remove the solvent. Column chromatography to obtain (2-(3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamido)ethyl)carbamic acid tert-butyl shown in formula (IV) ester;

4)将步骤3)所得如式(Ⅳ)所示的(2-(3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺基)乙基)氨基甲酸叔丁酯和三氟甲基乙酸在有机溶剂D中升温至回流反应,TLC跟踪反应进程,反应结束后蒸馏浓缩除去溶剂,蒸馏浓缩物经柱层析分离制得如式(Ⅴ)所示的N-(2-氨基乙基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺;4) tertiary (2-(3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamido)ethyl)carbamic acid shown in formula (IV) obtained in step 3) Butyl ester and trifluoromethyl acetic acid are warmed to reflux reaction in organic solvent D, TLC tracks the reaction progress, after the reaction is finished, the solvent is distilled and concentrated to remove the solvent, and the distillation concentrate is separated by column chromatography to obtain N as shown in formula (V). -(2-Aminoethyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide;

5)将步骤4)得到的式(Ⅴ)所示的N-(2-氨基乙基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺、有机溶剂E和三乙胺搅拌混合均匀后,滴加取代苯甲酰氯,于室温下搅拌反应,TLC跟踪反应进程,反应结束后旋蒸浓缩除去溶剂,旋蒸浓缩残留物经柱层析分离提纯制得如式(Ⅰ)所示的N-(2-苯甲酰胺)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺类化合物;5) N-(2-aminoethyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide represented by formula (V) obtained in step 4), organic After the solvent E and triethylamine are stirred and mixed uniformly, substituted benzoyl chloride is added dropwise, and the reaction is stirred at room temperature. TLC tracks the reaction progress. After the reaction is completed, the solvent is evaporated and concentrated to remove the solvent. The concentrated residue is separated and purified by column chromatography. To obtain N-(2-benzamide)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide compounds represented by formula (I);

其中,所述取代苯甲酰氯的苯环上的取代基数量为一个或多个,各个取代基各自独立地选自H、卤素、C1-C3烷基或C1-C3烷氧基。Wherein, the number of substituents on the benzene ring of the substituted benzoyl chloride is one or more, and each substituent is independently selected from H, halogen, C1-C3 alkyl or C1-C3 alkoxy.

所述的一种N-(2-苯甲酰胺)-1H-吡唑-4-甲酰胺类化合物的制备方法,其特征在于步骤1)中的有机溶剂A为乙酸酐,有机溶剂B为乙醇;步骤3)中的有机溶剂C、步骤4)中的有机溶剂D和步骤5)中的有机溶剂E均为二氯甲烷。The method for preparing a N-(2-benzamide)-1H-pyrazole-4-carboxamide compound is characterized in that the organic solvent A in step 1) is acetic anhydride, and the organic solvent B is ethanol ; The organic solvent C in step 3), the organic solvent D in step 4) and the organic solvent E in step 5) are all methylene chloride.

所述的一种N-(2-苯甲酰胺)-1H-吡唑-4-甲酰胺类化合物的制备方法,其特征在于步骤1)中,所述二氟乙酰乙酸乙酯、原甲酸三乙酯和甲基肼的投料摩尔比为1:1.1~1.5:1.1~1.5。Described a kind of preparation method of N-(2-benzamide)-1H-pyrazole-4-carboxamide compound, it is characterized in that in step 1), described ethyl difluoroacetoacetate, orthoformic acid triacetate The molar ratio of ethyl ester and methyl hydrazine is 1:1.1-1.5:1.1-1.5.

所述的一种N-(2-苯甲酰胺)-1H-吡唑-4-甲酰胺类化合物的制备方法,其特征在于步骤3)中,式(Ⅲ)所示的1-甲基-3-二氟甲基-1H-吡唑-4-甲酸与N-Boc-乙二胺的投料摩尔比为1:1.1~1.5;步骤4)中,式(Ⅳ)所示的(2-(3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺基)乙基)氨基甲酸叔丁酯和三氟甲基乙酸的投料摩尔比为1:1.05~1.2。The method for preparing a N-(2-benzamide)-1H-pyrazole-4-carboxamide compound is characterized in that in step 3), the 1-methyl- The molar ratio of 3-difluoromethyl-1H-pyrazole-4-carboxylic acid to N-Boc-ethylenediamine is 1:1.1 to 1.5; in step 4), (2-( The molar ratio of 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamido)ethyl)carbamate and trifluoromethylacetic acid is 1:1.05-1.2.

所述的一种N-(2-苯甲酰胺)-1H-吡唑-4-甲酰胺类化合物的制备方法,其特征在于步骤5)中,式(Ⅴ)所示的N-(2-氨基乙基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺与取代苯甲酰氯的投料摩尔比为1:1.05~1.2。Described a kind of preparation method of N-(2-benzamide)-1H-pyrazole-4-carboxamide compound, it is characterized in that in step 5), N-(2- The molar ratio of aminoethyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide to substituted benzoyl chloride is 1:1.05-1.2.

所述的一种N-(2-苯甲酰胺)-1H-吡唑-4-甲酰胺类化合物的制备方法,其特征在于步骤1)中有机溶剂A与二氟乙酰乙酸乙酯的摩尔比为2~4:1,有机溶剂B的体积用量以二氟乙酰乙酸乙酯的物质的量计为0.3~0.8ml/mmol;步骤3)中有机试剂C的体积用量以式(Ⅲ)所示的1-甲基-3-二氟甲基-1H-吡唑-4-甲酸的物质的量计为0.5~1.0ml/mmol;步骤4)中有机试剂D的体积用量以式(Ⅳ)所示的(2-(3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺基)乙基)氨基甲酸叔丁酯的物质的量计为5~8ml/mmol;步骤5)中有机试剂E的体积用量以式(Ⅴ)所示的N-(2-氨基乙基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺的物质的量计为5~8ml/mmol。Described a kind of preparation method of N-(2-benzamide)-1H-pyrazole-4-carboxamide compound, it is characterized in that in step 1) in the mol ratio of organic solvent A and ethyl difluoroacetoacetate is 2 to 4:1, and the volumetric dosage of organic solvent B is 0.3 to 0.8 ml/mmol based on the amount of ethyl difluoroacetoacetate; the volumetric dosage of organic solvent C in step 3) is shown in formula (III) The amount of the substance of the 1-methyl-3-difluoromethyl-1H-pyrazole-4-carboxylic acid is calculated as 0.5~1.0ml/mmol; In step 4), the volume dosage of the organic reagent D is represented by formula (IV) The amount of (2-(3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamido)ethyl)carbamic acid tert-butyl ester shown is 5 to 8 ml/mmol ; The volume consumption of organic reagent E in step 5) is N-(2-aminoethyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4- The amount of the formamide substance was 5 to 8 ml/mmol.

所述的一种N-(2-苯甲酰胺)-1H-吡唑-4-甲酰胺类化合物的制备方法,其特征在于步骤3)、步骤4)和步骤5)中柱层析分离的洗脱剂均采用体积比1:0.5~2的乙酸乙酯和石油醚混合液。Described a kind of preparation method of N-(2-benzamide)-1H-pyrazole-4-carboxamide compound, it is characterized in that step 3), step 4) and step 5) in column chromatography separation The eluent is a mixture of ethyl acetate and petroleum ether with a volume ratio of 1:0.5-2.

所述的一种N-(2-苯甲酰胺)-1H-吡唑-4-甲酰胺类化合物在制备杀菌剂中的应用。The application of the N-(2-benzamide)-1H-pyrazole-4-carboxamide compound in the preparation of fungicides.

本发明N-(2-苯甲酰胺)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺类化合物的合成工艺路线如下:The synthetic process route of N-(2-benzamide)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide compounds of the present invention is as follows:

与现有技术相比,本发明的有益效果主要体现在:本发明提供了一种N-(2-苯甲酰胺)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺类化合物及其制备方法与其制备杀菌剂中的应用,其制备方法简单、操作方便,得到的化合物在50ppm浓度下对水稻纹枯病菌抑制活性最好,抑制率达到了54.3%,本发明所述化合物为具有杀菌活性的新化合物,为新农药的研发提供了基础。Compared with the prior art, the beneficial effects of the present invention are mainly reflected in: the present invention provides a N-(2-benzamide)-3-(difluoromethyl)-1-methyl-1H-pyrazole -4-Carboxamide compound and its preparation method and its application in the preparation of fungicides, the preparation method is simple, the operation is convenient, the obtained compound has the best inhibitory activity against Rhizoctonia solani at a concentration of 50 ppm, and the inhibition rate reaches 54.3 %, the compound of the present invention is a new compound with bactericidal activity, which provides a basis for the research and development of new pesticides.

具体实施方式Detailed ways

下面结合具体实施例对本发明作进一步说明,但本发明的保护范围并不限于此。The present invention will be further described below with reference to specific embodiments, but the protection scope of the present invention is not limited thereto.

实施例1 3-(二氟甲基)-1-甲基-N-(2-(2-甲基苯甲酰氨基)乙基)-1H-吡唑-4-甲酰胺的制备Example 1 Preparation of 3-(difluoromethyl)-1-methyl-N-(2-(2-methylbenzamido)ethyl)-1H-pyrazole-4-carboxamide

1)1-甲基-3-三氟甲基-1H-吡唑-4-甲酸乙酯(Ⅱ)的合成:1) Synthesis of 1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxylic acid ethyl ester (II):

将二氟乙酰乙酸乙酯(50.0mmol)和原甲酸三乙酯(60mmol)在乙酸酐(150.0mmol)中回流反应8小时后(检测反应物转化完全),将反应液减压蒸馏浓缩除去多余原甲酸三乙酯和乙酸酐溶剂,在冰浴条件下将浓缩残留物加入到8.3g的40%甲基肼水溶液和25mL乙醇的混合溶液中,随后升温至50℃温度下进行反应,TLC跟踪反应进程,等到反应结束后蒸馏浓缩除去溶剂,蒸馏浓缩物中加入20mL乙酸乙酯和20mL饱和食盐水萃取、分层,取有机层用饱和食盐水洗涤2次(每次洗涤采用的饱和食盐水体积20mL),再经无水硫酸镁干燥后旋蒸除去残留的溶剂,制得式(Ⅱ)所示的1-甲基-3-二氟甲基-1H-吡唑-4-甲酸乙酯;After refluxing ethyl difluoroacetoacetate (50.0 mmol) and triethyl orthoformate (60 mmol) in acetic anhydride (150.0 mmol) for 8 hours (detecting the complete conversion of the reactants), the reaction solution was concentrated under reduced pressure to remove excess Triethyl orthoformate and acetic anhydride solvent, the concentrated residue was added to a mixed solution of 8.3 g of 40% methyl hydrazine aqueous solution and 25 mL of ethanol under ice bath conditions, and then the temperature was raised to 50 ° C for reaction, TLC tracking Reaction process, after the reaction is finished, distillation is concentrated to remove the solvent, and 20 mL of ethyl acetate and 20 mL of saturated brine are added to the distillation concentrate for extraction and layering, and the organic layer is washed twice with saturated brine (saturated brine used for each washing). volume 20mL), then dried over anhydrous magnesium sulfate, rotary evaporation to remove residual solvent, to obtain 1-methyl-3-difluoromethyl-1H-pyrazole-4-carboxylic acid ethyl ester represented by formula (II) ;

2)1-甲基-3-二氟甲基-1H-吡唑-4-甲酸(Ⅲ)的合成:2) Synthesis of 1-methyl-3-difluoromethyl-1H-pyrazole-4-carboxylic acid (III):

在100mL的反应瓶中,将式(Ⅱ)所示的1-甲基-3-二氟甲基-1H-吡唑-4-甲酸乙酯(38mmol)加入,然后加入质量浓度为10%的NaOH水溶液30mL,升温至60℃搅拌至反应液透明后,自然冷却至室温,反应液中加酸调节pH到2.0左右,析出固体,抽滤,滤渣经水洗、干燥后,制得式(Ⅲ)所示的1-甲基-3-二氟甲基-1H-吡唑-4-甲酸。In a 100mL reaction flask, add 1-methyl-3-difluoromethyl-1H-pyrazole-4-carboxylic acid ethyl ester (38mmol) represented by formula (II), and then add 10% mass concentration of 30 mL of NaOH aqueous solution was heated to 60 °C and stirred until the reaction solution was transparent, then cooled to room temperature naturally, acid was added to the reaction solution to adjust the pH to about 2.0, a solid was precipitated, suction filtered, and the filter residue was washed with water and dried to obtain formula (III) 1-Methyl-3-difluoromethyl-1H-pyrazole-4-carboxylic acid shown.

3)(2-(3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺基)乙基)氨基甲酸叔丁酯(Ⅳ)的合成:3) Synthesis of (2-(3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamido)ethyl) tert-butyl carbamate (IV):

式(Ⅲ)所示的1-甲基-3-二氟甲基-1H-吡唑-4-甲酸(30mmol)与10mL二氯亚砜混合并升温至回流反应,待反应液由浑浊变为澄清透明后,继续反应30min,反应停止,冷却至室温后,浓缩除去多余的氯化亚砜,浓缩残留物用10mL二氯甲烷稀释混合,配制得到溶液A备用。1-Methyl-3-difluoromethyl-1H-pyrazole-4-carboxylic acid (30 mmol) represented by formula (III) was mixed with 10 mL of thionyl chloride and heated to reflux for reaction, and the reaction solution changed from turbidity to After it became clear and transparent, the reaction was continued for 30 min, the reaction stopped, and after cooling to room temperature, the excess thionyl chloride was removed by concentration, and the concentrated residue was diluted and mixed with 10 mL of dichloromethane to prepare solution A for later use.

将上述配制的溶液A,逐滴加入到15mL二氯甲烷、N-Boc-乙二胺(40.0mmol)和4mL三乙胺的混合液中,于室温下搅拌反应,TLC跟踪反应进程;反应结束后浓缩除去溶剂,浓缩残留物经柱层析分离提纯(洗脱剂为体积比1:1石油醚和乙酸乙酯)得到如式(Ⅳ)所示的(2-(3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺基)乙基)氨基甲酸叔丁酯;The above-prepared solution A was added dropwise to a mixture of 15 mL of dichloromethane, N-Boc-ethylenediamine (40.0 mmol) and 4 mL of triethylamine, and the reaction was stirred at room temperature, and the TLC tracked the reaction process; the reaction ended After concentrating to remove the solvent, the concentrated residue is separated and purified by column chromatography (eluent is petroleum ether and ethyl acetate in a volume ratio of 1:1) to obtain (2-(3-(difluoromethyl) as shown in formula (IV). yl)-1-methyl-1H-pyrazole-4-carboxamido)ethyl)carbamic acid tert-butyl ester;

4)N-(2-氨基乙基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺(Ⅴ)的合成:4) Synthesis of N-(2-aminoethyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide (V):

将式(Ⅳ)所示的(2-(3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺基)乙基)氨基甲酸叔丁酯(1.5mmol)中加入10mL二氯甲烷,搅拌均匀后,加入三氟甲基乙酸(1.6mmol),升温回流反应2h,TLC跟踪反应进程;反应结束后浓缩除去溶剂,浓缩残留物经柱层析分离提纯(洗脱剂为体积比1:1石油醚和乙酸乙酯)得到式(Ⅴ)所示的N-(2-氨基乙基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺。(2-(3-(difluoromethyl)-1-methyl-1H-pyrazol-4-carboxamido)ethyl) tert-butyl carbamate (1.5mmol) represented by formula (IV) 10 mL of dichloromethane was added, and after stirring evenly, trifluoromethyl acetic acid (1.6 mmol) was added, the temperature was raised and refluxed for 2 h, and the reaction progress was followed by TLC; after the reaction was completed, the solvent was concentrated and removed, and the concentrated residue was separated and purified by column chromatography (eluting The agent is petroleum ether and ethyl acetate in a volume ratio of 1:1) to obtain N-(2-aminoethyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole represented by formula (V) -4-Carboxamide.

5)3-(二氟甲基)-1-甲基-N-(2-(2-甲基苯甲酰氨基)乙基)-1H-吡唑-4-甲酰胺(G1)的合成:5) Synthesis of 3-(difluoromethyl)-1-methyl-N-(2-(2-methylbenzamido)ethyl)-1H-pyrazole-4-carboxamide (G1):

将式(Ⅴ)所示的N-(2-氨基乙基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺(1.5mmol)中加入10mL二氯甲烷和1mL三乙胺,搅拌均匀后,滴加2-甲基苯甲酰氯(1.6mmol),室温搅拌反应,TLC跟踪反应进程;反应结束后浓缩除去溶剂,浓缩残留物经柱层析分离提纯(洗脱剂为体积比1:1石油醚和乙酸乙酯)制得式(G1)所示的3-(二氟甲基)-1-甲基-N-(2-(2-甲基苯甲酰氨基)乙基)-1H-吡唑-4-甲酰胺。N-(2-aminoethyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide (1.5 mmol) represented by formula (V) was added with 10 mL of dichloromethane Methane and 1 mL of triethylamine were stirred evenly, then 2-methylbenzoyl chloride (1.6 mmol) was added dropwise, the reaction was stirred at room temperature, and the reaction progress was followed by TLC; after the reaction was completed, the solvent was concentrated and removed, and the concentrated residue was separated and purified by column chromatography (The eluent is petroleum ether and ethyl acetate in a volume ratio of 1:1) to obtain 3-(difluoromethyl)-1-methyl-N-(2-(2-methyl) represented by formula (G1) Benzoamido)ethyl)-1H-pyrazole-4-carboxamide.

3-(二氟甲基)-1-甲基-N-(2-(2-甲基苯甲酰氨基)乙基)-1H-吡唑-4-甲酰胺:白色固体,产率:68.3%,熔点:113-116℃;1HNMR(CDCl3,500MHz),δ:7.85(s,1H,py),7.37-7.29(m,1H,ph),7.28(s,1H,ph),7.23-7.17(m,2H,ph),7.05(t,J=54.0Hz,1H,CHF2),6.65(s,1H,NH),3.85(s,3H,CH3),3.66-3.75(m,4H,CH2),2.40(s,3H,CH3)。3-(Difluoromethyl)-1-methyl-N-(2-(2-methylbenzamido)ethyl)-1H-pyrazole-4-carboxamide: white solid, yield: 68.3 %, melting point: 113-116°C; 1 HNMR (CDCl 3 , 500MHz), δ: 7.85 (s, 1H, py), 7.37-7.29 (m, 1H, ph), 7.28 (s, 1H, ph), 7.23 -7.17(m, 2H, ph), 7.05(t, J=54.0Hz, 1H, CHF 2 ), 6.65(s, 1H, NH), 3.85(s, 3H, CH 3 ), 3.66-3.75(m, 4H, CH2 ), 2.40 (s, 3H, CH3 ).

实施例2 N-(2-(2,6-二氯苯甲酰胺)乙基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺Example 2 N-(2-(2,6-dichlorobenzamide)ethyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide

将实施例1步骤5)中的2-甲基苯甲酰氯替换为同等摩尔量的2,6-二氯苯甲酰氯,其他操作同实施例1,制得目标化合物式(G2)所示的N-(2-(2,6-二氯苯甲酰胺)乙基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺;2-methylbenzoyl chloride in step 5) of Example 1 is replaced with 2,6-dichlorobenzoyl chloride of an equivalent molar amount, and other operations are the same as in Example 1, to obtain the target compound shown in the formula (G2). N-(2-(2,6-Dichlorobenzamide)ethyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide;

N-(2-(2,6-二氯苯甲酰胺)乙基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺:白色固体,产率:63.5%,熔点:109-113℃;1H NMR(CDCl3,500MHz),δ:7.86(s,1H,py),7.35-7.31(m,2H,ph),7.29(s,1H,ph),7.12-6.89(m,2H,ph,CHF2),6.52(s,1H,NH),3.94(s,3H,CH3),3.75-3.68(m,4H,CH2).N-(2-(2,6-Dichlorobenzamide)ethyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide: white solid, yield: 63.5%, melting point: 109-113°C; 1 H NMR (CDCl 3 , 500MHz), δ: 7.86 (s, 1H, py), 7.35-7.31 (m, 2H, ph), 7.29 (s, 1H, ph) , 7.12-6.89 (m, 2H, ph, CHF 2 ), 6.52 (s, 1H, NH), 3.94 (s, 3H, CH 3 ), 3.75-3.68 (m, 4H, CH 2 ).

实施例3 N-(2-(2,3-二氯苯甲酰胺)乙基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺的制备Example 3 Preparation of N-(2-(2,3-dichlorobenzamide)ethyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide

将实施例1步骤5)中的2-甲基苯甲酰氯替换为同等摩尔量的2,3-二氯苯甲酰氯,其他操作同实施例1,获得如式(G3)所示的N-(2-(2,3-二氯苯甲酰胺)乙基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺;2-methylbenzoyl chloride in step 5) of Example 1 was replaced with 2,3-dichlorobenzoyl chloride in an equivalent molar amount, and other operations were the same as in Example 1 to obtain N- (2-(2,3-Dichlorobenzamide)ethyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide;

N-(2-(2,3-二氯苯甲酰胺)乙基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺:白色固体,产率:53.1%,熔点:105-107℃;1H NMR(CDCl3,500MHz),δ:7.88(s,1H,py),7.53-7.58(m,1H,ph),7.39-7.45(m,1H,ph),7.25(t,J=8.0Hz,1H,ph),7.08-6.85(m,2H,ph,CHF2),6.82(s,1H,NH),3.93(s,3H,CH3),3.69-3.75(m,4H,CH2).N-(2-(2,3-Dichlorobenzamide)ethyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide: white solid, yield: 53.1%, melting point: 105-107°C; 1 H NMR (CDCl 3 , 500MHz), δ: 7.88 (s, 1H, py), 7.53-7.58 (m, 1H, ph), 7.39-7.45 (m, 1H, ph), 7.25 (t, J=8.0Hz, 1H, ph), 7.08-6.85 (m, 2H, ph, CHF 2 ), 6.82 (s, 1H, NH), 3.93 (s, 3H, CH 3 ), 3.69-3.75 (m, 4H, CH 2 ).

实施例4 3-(二氟甲基)-N-(2-(4-甲氧基苯甲酰氨基)乙基)-1-甲基-1H-吡唑-4-甲酰胺的制备Example 4 Preparation of 3-(difluoromethyl)-N-(2-(4-methoxybenzamido)ethyl)-1-methyl-1H-pyrazole-4-carboxamide

将实施例1步骤5)中的2-甲基苯甲酰氯替换为同等摩尔量的4-甲氧基苯甲酰氯,其他操作同实施例1,获得如式(G4)所示的3-(二氟甲基)-N-(2-(4-甲氧基苯甲酰氨基)乙基)-1-甲基-1H-吡唑-4-甲酰胺;Replace the 2-methylbenzoyl chloride in step 5 of Example 1 with 4-methoxybenzoyl chloride of an equivalent molar amount, and other operations are the same as in Example 1 to obtain 3-( Difluoromethyl)-N-(2-(4-methoxybenzamido)ethyl)-1-methyl-1H-pyrazole-4-carboxamide;

3-(二氟甲基)-N-(2-(4-甲氧基苯甲酰氨基)乙基)-1-甲基-1H-吡唑-4-甲酰胺:白色固体,产率:47.5%,熔点:96-98℃;1H NMR(CDCl3,500MHz),δ:7.88(d,J=9.0Hz,2H,py,ph),7.84(s,1H,ph),7.08(s,1H,ph),6.94(t,J=54.0Hz,1H,CHF2),6.81(d,J=9.0Hz,1H,ph),6.65(s,1H,NH),3.78(s,3H,CH3),3.75(s,3H,CH3O),3.69-3.74(m,4H,CH2).3-(Difluoromethyl)-N-(2-(4-methoxybenzamido)ethyl)-1-methyl-1H-pyrazole-4-carboxamide: white solid, yield: 47.5%, melting point: 96-98°C; 1 H NMR (CDCl 3 , 500MHz), δ: 7.88(d, J=9.0Hz, 2H, py, ph), 7.84(s, 1H, ph), 7.08(s) , 1H, ph), 6.94 (t, J=54.0Hz, 1H, CHF 2 ), 6.81 (d, J=9.0Hz, 1H, ph), 6.65 (s, 1H, NH), 3.78 (s, 3H, CH 3 ), 3.75 (s, 3H, CH 3 O), 3.69-3.74 (m, 4H, CH 2 ).

实施例5 N-(2-(2,4-二氯苯甲酰胺)乙基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺的制备Example 5 Preparation of N-(2-(2,4-dichlorobenzamide)ethyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide

将实施例1步骤5)中的2-甲基苯甲酰氯替换为同等摩尔量的2,4-二氯苯甲酰氯,其他操作同实施例1,获得如式(G5)所示的N-(2-(2,4-二氯苯甲酰胺)乙基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺;2-methylbenzoyl chloride in step 5) of Example 1 was replaced with 2,4-dichlorobenzoyl chloride in an equivalent molar amount, and other operations were the same as in Example 1 to obtain N- (2-(2,4-Dichlorobenzamide)ethyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide;

N-(2-(2,4-二氯苯甲酰胺)乙基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺:白色固体,产率46.2%,熔点:93-97℃;1H NMR(CDCl3,500MHz),δ:7.86(s,1H,py),7.63-7.59(m,1H,ph),7.52(d,J=8.0Hz,1H,ph),7.20(t,J=8.0Hz,1H,ph),7.03-6.80(m,2H,ph,CHF2),6.61(s,1H,NH),3.82(s,3H,CH3),3.73-3.78(m,4H,CH2).N-(2-(2,4-Dichlorobenzamide)ethyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide: white solid, yield 46.2 %, melting point: 93-97°C; 1 H NMR (CDCl 3 , 500MHz), δ: 7.86 (s, 1H, py), 7.63-7.59 (m, 1H, ph), 7.52 (d, J=8.0Hz, 1H, ph), 7.20 (t, J=8.0Hz, 1H, ph), 7.03-6.80 (m, 2H, ph, CHF 2 ), 6.61 (s, 1H, NH), 3.82 (s, 3H, CH 3 ), 3.73-3.78(m, 4H, CH 2 ).

实施例6 N-(2-苯并酰氨基乙基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺的制备Example 6 Preparation of N-(2-benzoylaminoethyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide

将实施例1步骤5)中的2-甲基苯甲酰氯替换为同等摩尔量的苯甲酰氯,其他操作同实施例1,获得如式(G6)所示的N-(2-苯并酰氨基乙基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺;The 2-methylbenzoyl chloride in Example 1, step 5) was replaced with the same molar amount of benzoyl chloride, and other operations were the same as in Example 1 to obtain N-(2-benzoyl chloride as shown in formula (G6) aminoethyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide;

N-(2-苯并酰氨基乙基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲酰胺:白色固体,产率:51.7%,熔点:103-106℃;1H NMR(CDCl3,500MHz),δ:7.94-8.04(m,2H,py,ph),7.84(s,1H,ph),7.47(m,1H,ph),7.34(t,J=8.0Hz,2H,ph),6.93(t,J=54.0Hz,1H,CHF2),6.67(s,1H,NH),3.77(s,3H,CH3),3.71-3.76(m,4H,CH2).N-(2-Benzamidoethyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide: white solid, yield: 51.7%, melting point: 103- 106°C; 1 H NMR (CDCl 3 , 500MHz), δ: 7.94-8.04 (m, 2H, py, ph), 7.84 (s, 1H, ph), 7.47 (m, 1H, ph), 7.34 (t, J=8.0Hz, 2H, ph), 6.93 (t, J=54.0Hz, 1H, CHF 2 ), 6.67 (s, 1H, NH), 3.77 (s, 3H, CH 3 ), 3.71-3.76 (m, 4H, CH 2 ).

实施例7杀菌活性测试Example 7 Bactericidal activity test

试验对象:番茄早疫病菌(Alternaria solani)、小麦赤霉病菌(Gibberellazeae)、马铃薯晚疫病菌(Phytophthora infestans)、辣椒疫霉病菌(Phytophthoracapsici)、油菜菌核病菌(Sclerotinia sclerotiorum)、黄瓜灰霉病菌(Botrytiscinerea)、水稻纹枯病菌(Riziocotinia solani)、黄瓜枯萎病菌(Fusarium oxysporum)、花生褐斑病菌(Cercospora arachidicola)以及苹果轮纹病菌(Botryosphaeriaberengriana)。Test objects: Alternaria solani, Gibberellazeae, Phytophthora infestans, Phytophthoracapsici, Sclerotinia sclerotiorum, Botrytis cucumber (Botrytiscinerea), Riziocotinia solani, Cucumber Fusarium oxysporum, Cercospora arachidicola, and Botryosphaeria berengriana.

将实施例1~6制备的式(G1)~式(G6)所示化合物,分别标记为待测化合物,并按以下方式进行杀菌活性测试:The compounds represented by formula (G1) to formula (G6) prepared in Examples 1 to 6 were respectively marked as compounds to be tested, and the bactericidal activity test was carried out in the following manner:

试验处理:各待测化合物用DMSO溶解成1%EC母液备用。采用抑菌圈法,评价待测化合物在50ppm剂量下对试验靶标的室内杀菌活性,另设溶剂清水对照(QCK),另设有效含量为50ppm的氟唑菌酰胺对照(FP)。Experimental treatment: each compound to be tested was dissolved in DMSO into a 1% EC stock solution for later use. The inhibition zone method was used to evaluate the indoor bactericidal activity of the tested compounds against the test target at a dose of 50 ppm. A solvent clear water control (QCK) and a fluoxamid control (FP) with an effective content of 50 ppm were also set up.

试验方法:用移液枪吸取50微升上述配置的EC母液,溶于2.95mL的吐温水中,配成待测化合物的有效浓度为500ppm的药液。用移液枪吸取1mL药液放入已灭菌的培养皿中,再放入9mL的PDA培养基,摇匀,冷却。用打孔器打取圆形菌饼后用接种针挑至培养皿中央,然后将培养皿置于培养箱27℃中培养,48~72h后测量菌落直径。菌落纯生长量为菌落平均直径与菌饼直径的差值,抑菌率(%)计算方法参照如下公式进行计算。Test method: suck 50 microliters of the EC mother solution prepared above with a pipette, dissolve it in 2.95 mL of Tween water, and prepare a medicinal solution with an effective concentration of 500 ppm of the compound to be tested. Pipette 1mL of liquid medicine into a sterilized petri dish, then put 9mL of PDA medium, shake well, and cool. Use a hole punch to punch out the circular bacterial cake and pick it to the center of the petri dish with an inoculating needle, then place the petri dish in an incubator at 27°C for cultivation, and measure the colony diameter after 48 to 72 hours. The pure growth of the colony is the difference between the average diameter of the colony and the diameter of the bacterial cake, and the calculation method of the bacteriostatic rate (%) is calculated by referring to the following formula.

上述计算公式中的对照菌落纯生长量,是指清水对照(QCK)测试下的菌落纯生长量。The pure growth of the control colony in the above calculation formula refers to the pure growth of the colony under the clear water control (QCK) test.

杀菌活性测试结果如表1所示。The bactericidal activity test results are shown in Table 1.

表1 50ppm下各化合物的杀菌活性(%防效)Table 1 Bactericidal activity (% control effect) of each compound at 50 ppm

由表1可知G系列的化合物仅对小麦赤霉病、黄瓜灰霉病、水稻纹枯病有活性,特别是对水稻纹枯病的抑制率,化合物G3、G5、G6的抑制效果都能达到50%以上。化合物G5对小麦赤霉病的抑制效果是最好的,达到了53.6%。化合物G3除了对水稻纹枯病的抑制率达到了54.3%。化合物G6除了对水稻纹枯病的抑制率达到了50%,对黄瓜灰霉病的抑制率也达到了43.9%。It can be seen from Table 1 that the compounds of the G series are only active against wheat scab, cucumber botrytis, and rice sheath blight, especially the inhibition rate of rice sheath blight, and the inhibitory effects of compounds G3, G5, and G6 can be achieved. above 50. Compound G5 had the best inhibitory effect on wheat scab, reaching 53.6%. In addition to compound G3, the inhibition rate of rice sheath blight reached 54.3%. In addition to inhibiting rice sheath blight by 50%, compound G6 also inhibited cucumber botrytis cinerea by 43.9%.

本说明书所述的内容仅仅是对发明构思实现形式的列举,本发明的保护范围不应当被视为仅限于实施例所陈述的具体形式。The content described in this specification is only an enumeration of the realization forms of the inventive concept, and the protection scope of the present invention should not be regarded as being limited to the specific forms stated in the embodiments.

Claims (10)

1. An N- (2-benzamide) -1H-pyrazole-4-carboxamide compound, namely an N- (2-benzamide) -3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxamide compound, is characterized in that the structural formula is shown as the formula (I):
in formula (I): r is phenyl or substituted phenyl, the number of the substituent groups on the benzene ring of the substituted phenyl is one or more, and each substituent group is independently selected from halogen, C1-C3 alkyl or C1-C3 alkoxy.
2. A N- (2-benzamide) -1H-pyrazole-4-carboxamide according to claim 1, characterized in that in formula (i) R is one of the following: 2-methylphenyl, 2, 6-dichlorophenyl, 2, 3-dichlorophenyl, 4-methoxyphenyl, 2, 4-dichlorophenyl and phenyl.
3. A process for the preparation of N- (2-benzamide) -1H-pyrazole-4-carboxamides according to claim 1 or 2, characterized by comprising the steps of:
1) heating ethyl difluoroacetoacetate and triethyl orthoformate in an organic solvent A to reflux reaction, concentrating to remove the solvent after the reaction is finished, adding the concentrated residue into a mixed solution of a methylhydrazine aqueous solution and an organic solvent B, stirring and reacting at the temperature of 45-60 ℃, and tracking the reaction process by TLC; after the reaction is finished, carrying out post-treatment on the reaction solution to obtain 1-methyl-3-difluoromethyl-1H-pyrazole-4-ethyl formate shown in a formula (II);
2) adding the 1-methyl-3-difluoromethyl-1H-pyrazole-4-ethyl formate shown in the formula (II) obtained in the step 1) into a NaOH aqueous solution with the mass concentration of 8-12%, stirring and reacting at the temperature of 55-70 ℃ until a reaction liquid system is transparent, naturally cooling to room temperature, adding acid to adjust the pH of the reaction liquid to 1.5-3.0, separating out a solid, performing suction filtration, and drying filter residues to obtain 1-methyl-3-difluoromethyl-1H-pyrazole-4-formic acid shown in the formula (III);
3) heating the 1-methyl-3-difluoromethyl-1H-pyrazole-4-formic acid shown in the formula (III) obtained in the step 2) in thionyl chloride to reflux reaction, concentrating to remove excessive thionyl chloride after the reaction is finished, stirring and reacting the concentrated residue with N-Boc-ethylenediamine and triethylamine in an organic solvent C at room temperature, tracking the reaction process by TLC, distilling and concentrating to remove the solvent after the reaction is finished, and separating the distilled and concentrated residue by column chromatography to obtain (2- (3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxamido) ethyl) carbamic acid tert-butyl ester shown in the formula (IV);
4) heating the tert-butyl (2- (3- (difluoromethyl) -1-methyl-1H-pyrazole-4-formamido) ethyl) carbamate obtained in the step 3) and trifluoromethyl acetic acid in an organic solvent D to reflux reaction, tracking the reaction process by TLC, distilling and concentrating to remove the solvent after the reaction is finished, and separating the distilled concentrate by column chromatography to obtain the N- (2-aminoethyl) -3- (difluoromethyl) -1-methyl-1H-pyrazole-4-formamide shown in the formula (V);
5) uniformly stirring and mixing the N- (2-aminoethyl) -3- (difluoromethyl) -1-methyl-1H-pyrazole-4-formamide shown in the formula (V) obtained in the step 4), an organic solvent E and triethylamine, then dropwise adding substituted benzoyl chloride, stirring and reacting at room temperature, tracking the reaction process by TLC, performing rotary evaporation and concentration after the reaction is finished to remove the solvent, and performing column chromatography separation and purification on the rotary evaporation and concentration residue to obtain the N- (2-benzamide) -3- (difluoromethyl) -1-methyl-1H-pyrazole-4-formamide shown in the formula (I);
wherein the number of the substituent groups on the benzene ring of the substituted benzoyl chloride is one or more, and each substituent group is independently selected from H, halogen, C1-C3 alkyl or C1-C3 alkoxy.
4. The process for preparing N- (2-benzamide) -1H-pyrazole-4-carboxamide compound according to claim 3, wherein the organic solvent A in step 1) is acetic anhydride and the organic solvent B is ethanol; the organic solvent C in the step 3), the organic solvent D in the step 4) and the organic solvent E in the step 5) are all dichloromethane.
5. The method for preparing N- (2-benzamide) -1H-pyrazole-4-carboxamide compound according to claim 3, wherein in step 1), the molar ratio of ethyl difluoroacetoacetate, triethyl orthoformate and methylhydrazine is 1: 1.1-1.5.
6. The method for preparing an N- (2-benzamide) -1H-pyrazole-4-carboxamide compound according to claim 3, wherein in step 3), the charging molar ratio of 1-methyl-3-difluoromethyl-1H-pyrazole-4-carboxylic acid represented by formula (III) to N-Boc-ethylenediamine is 1: 1.1-1.5; in the step 4), the feeding molar ratio of the tert-butyl (2- (3- (difluoromethyl) -1-methyl-1H-pyrazole-4-formamido) ethyl) carbamate shown in the formula (IV) to the trifluoromethyl acetic acid is 1: 1.05-1.2.
7. The method for preparing an N- (2-benzamide) -1H-pyrazole-4-carboxamide according to claim 3, wherein in step 5), the molar ratio of N- (2-aminoethyl) -3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxamide represented by formula (v) to the substituted benzoyl chloride is 1:1.05 to 1.2.
8. The process for preparing N- (2-benzamide) -1H-pyrazole-4-carboxamide compound according to claim 3, wherein the molar ratio of organic solvent A to ethyl difluoroacetoacetate in step 1) is 2-4: 1, the volume of organic solvent B is 0.3-0.8 ml/mmol based on the amount of ethyl difluoroacetoacetate; the volume dosage of the organic reagent C in the step 3) is 0.5-1.0 ml/mmol based on the amount of the 1-methyl-3-difluoromethyl-1H-pyrazole-4-carboxylic acid shown in the formula (III); the volume usage amount of the organic reagent D in the step 4) is 5-8 ml/mmol based on the substance amount of (2- (3- (difluoromethyl) -1-methyl-1H-pyrazole-4-formamido) ethyl) carbamic acid tert-butyl ester shown in a formula (IV); the volume usage amount of the organic reagent E in the step 5) is 5-8 ml/mmol based on the amount of the N- (2-aminoethyl) -3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxamide shown in the formula (V).
9. The method for preparing N- (2-benzamide) -1H-pyrazole-4-carboxamide compound according to claim 3, wherein the eluents for column chromatography in step 3), step 4) and step 5) are mixed solution of ethyl acetate and petroleum ether in a volume ratio of 1: 0.5-2.
10. Use of an N- (2-benzamide) -1H-pyrazole-4-carboxamide compound as claimed in claim 1 or 2 for the preparation of fungicides.
CN201911025678.4A 2019-10-25 2019-10-25 N- (2-benzamide) -1H-pyrazole-4-formamide compound and preparation method and application thereof Pending CN110615764A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911025678.4A CN110615764A (en) 2019-10-25 2019-10-25 N- (2-benzamide) -1H-pyrazole-4-formamide compound and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911025678.4A CN110615764A (en) 2019-10-25 2019-10-25 N- (2-benzamide) -1H-pyrazole-4-formamide compound and preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN110615764A true CN110615764A (en) 2019-12-27

Family

ID=68926729

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911025678.4A Pending CN110615764A (en) 2019-10-25 2019-10-25 N- (2-benzamide) -1H-pyrazole-4-formamide compound and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN110615764A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110669007A (en) * 2019-10-25 2020-01-10 浙江工业大学 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic ester compound and preparation method and application thereof
CN112175030A (en) * 2020-11-11 2021-01-05 铜仁学院 Acetylglucose triazole benzamide compound and its synthesis method and application

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102918028A (en) * 2010-06-03 2013-02-06 拜尔农科股份公司 N-[(het)arylalkyl)] pyrazole (thio)carboxamides and their heterosubstituted analogues

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102918028A (en) * 2010-06-03 2013-02-06 拜尔农科股份公司 N-[(het)arylalkyl)] pyrazole (thio)carboxamides and their heterosubstituted analogues

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
叶发青 等: "《药物化学》", 30 June 2012, 浙江大学出版社 *
姚其正 等: "《药物合成反应》", 30 September 2012, 中国医药科技出版社 *
王翰 等: "新型吡唑酰胺类化合物的设计合成、杀菌活性与分子对接研究", 《中国化工学会农药专业委员会第十八届年会论文集》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110669007A (en) * 2019-10-25 2020-01-10 浙江工业大学 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic ester compound and preparation method and application thereof
CN112175030A (en) * 2020-11-11 2021-01-05 铜仁学院 Acetylglucose triazole benzamide compound and its synthesis method and application

Similar Documents

Publication Publication Date Title
RU2647853C2 (en) Methods for producing certain 2-(pyridine-3-yl)thiazoles
CN103781764B (en) The autofrettage of noxious organism control agent
US20050197353A1 (en) Indole derivatives or benzimidazole derivatives for modulating IkB kinase
CN103030606B (en) Thiadiazole-containing amide derivatives, and preparation and application thereof
CN104892581B (en) 2-methyl-4-amino-5-(substituted-1,2,3-triazolyl)methylpyridine derivatives having bactericidal activity, and preparation method and application thereof
CN111943944B (en) Ethylthio-containing pyridine-bis-1, 2, 4-oxadiazole substituted benzamide compound and preparation method and application thereof
CA3091342A1 (en) Susbstituted aryl and heteroaryl acetamide derivatives and pharmaceutical compositions thereof useful as p300/cbp hat_inhibitors
CN110615764A (en) N- (2-benzamide) -1H-pyrazole-4-formamide compound and preparation method and application thereof
US4598077A (en) Amidine derivatives and cardiotonic compositions
CN111518104A (en) A thiouracil-containing 1,2,4-triazolo[1,5-a]pyrimidine compound and its preparation method and application
CN115260175A (en) 5- (pyrazole-5-yl) -1,2,4-oxadiazole substituted benzamide compound and preparation method and application thereof
CN112174954A (en) Beta-carboline amide compound containing beta-arylamine and application of beta-carboline amide compound as agricultural bactericide
CN107935930A (en) 3 difluoromethyl 1H pyrazoles of a kind of 1 methyl, 4 amide derivatives and preparation method and application
CN113563281B (en) Benzophenone compound containing 1,3, 4-thiadiazole thioether structure and application thereof
CN110669007A (en) 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxylic ester compound and preparation method and application thereof
CN106986801A (en) A kind of new methoxy acrylic ester compounds and its preparation method and application
CN115124462B (en) 2,3-Dimethyl-6,8-difluoroquinoline-4-ether compound and its preparation method and application
CN102993182A (en) Pyrrolidine diketone compound containing pyridine hydrazine group, preparation method and application of compound
CN111116494B (en) Amide compounds containing quinazolinedione structure, preparation method and application thereof
CN107935929A (en) 3 trifluoromethyl 1H pyrazoles of a kind of 1 methyl, 4 amide derivatives and preparation method and application
CN110734403B (en) (S)-2-(1H-pyrazole-4-carboxamido) propyl benzoate compound and its preparation method and application
CN103030607B (en) Thiadiazole-containing amide derivative, and preparation and application thereof as plant growth regulator
CN108117520A (en) A kind of 1,3- dimethyl -1H- pyrazoles -4- amide derivatives and preparation method and application
CN106432245B (en) A kind of 1,2,4- triazole derivatives of the structure containing benzopyrazines and its preparation method and application
CN110713458A (en) N- (2-benzoylaminoethyl) -2-chloronicotinamide compound and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20191227

RJ01 Rejection of invention patent application after publication